Skip to main content
Top
Published in: Heart and Vessels 4/2023

01-11-2022 | Heart Failure | Original Article

Serum potassium in elderly heart failure patients as a predictor of readmission within 1 year

Authors: Gechu Shang, Yan Gao, Kewei Liu, Xiaoyong Wang

Published in: Heart and Vessels | Issue 4/2023

Login to get access

Abstract

Blood potassium levels are associated with adverse outcomes in patients with congestive heart failure (HF). However, it is unclear whether there are differences in outcome events in elderly patients with different blood potassium levels at the time of emergency readmission within 1 year. This study used data from patients hospitalized with HF, integrating electronic medical records from the PhysioNet restricted health data database and external outcome data. We conducted a retrospective study of HF patients aged 60 years and older, using baseline data, comorbidities, laboratory tests, and medication use as covariates to analyze the effect of serum potassium levels on outcome events, with the primary outcome being readmission within 1 year. A priori was used to calculate the sample size, and this retrospective cohort study included a total of 788 elderly HF patients, of whom 20.3% had hypokalaemia (K+  < 3.5 mmol/L) and 14.7% had hyperkalemia (K+  > 4.7 mmol/L). According to a multivariate Cox regression model, patients with hyperkalemia had a shorter time interval between readmissions within 1 year, with a hazard ratio (HR) and its 95% CI of 1.134 (1.006–1.279). Three models were used to analyze patients with different blood potassium levels and, after correction, the high potassium group was at high risk relative to the low and normal groups, with significant differences in outcome events, with HRs and their 95% CI of 1.266 (1.03–1.557), 1.245 (1.01–1.534), and 1.439 (1.142–1.812), respectively. The robustness of the model was also demonstrated by competing risk models with subgroup analysis, showing that blood potassium levels had a stable effect on outcome events and were not altered by covariates (age, sex, diabetes, chronic kidney disease, NT-proBNP, high-sensitivity troponin, and glomerular filtration rate). The results show that high blood potassium levels are associated with the outcome event of readmission within 1 year in elderly patients with HF. Blood potassium levels at the time of the first hospitalization may therefore be a valuable predictor.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol 75:1074–1082CrossRefPubMed Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol 75:1074–1082CrossRefPubMed
2.
go back to reference Wong CW, Tafuro J, Azam Z, Satchithananda D, Duckett S, Barker D, Patwala A, Ahmed FZ, Mallen C, Kwok CS (2021) Misdiagnosis of heart failure: a systematic review of the literature. J Card Fail 27:925–933CrossRefPubMed Wong CW, Tafuro J, Azam Z, Satchithananda D, Duckett S, Barker D, Patwala A, Ahmed FZ, Mallen C, Kwok CS (2021) Misdiagnosis of heart failure: a systematic review of the literature. J Card Fail 27:925–933CrossRefPubMed
3.
go back to reference Nair N, Gongora E (2020) Stem cell therapy in heart failure: where do we stand today? Biochim Biophys Acta Mol Basis Dis 1866:165489CrossRefPubMed Nair N, Gongora E (2020) Stem cell therapy in heart failure: where do we stand today? Biochim Biophys Acta Mol Basis Dis 1866:165489CrossRefPubMed
4.
go back to reference Ide T, Kaku H, Matsushima S, Tohyama T, Enzan N, Funakoshi K, Sumita Y, Nakai M, Nishimura K, Miyamoto Y, Tsuchihashi-Makaya M, Hatano M, Komuro I, Tsutsui H, JROADHF Investigators (2021) Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese registry of acute decompensated heart failure (JROADHF). Circ J 85:1438–1450CrossRefPubMed Ide T, Kaku H, Matsushima S, Tohyama T, Enzan N, Funakoshi K, Sumita Y, Nakai M, Nishimura K, Miyamoto Y, Tsuchihashi-Makaya M, Hatano M, Komuro I, Tsutsui H, JROADHF Investigators (2021) Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese registry of acute decompensated heart failure (JROADHF). Circ J 85:1438–1450CrossRefPubMed
5.
go back to reference Pagliaro BR, Cannata F, Stefanini GG, Bolognese L (2020) Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev 25:53–65CrossRefPubMed Pagliaro BR, Cannata F, Stefanini GG, Bolognese L (2020) Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev 25:53–65CrossRefPubMed
6.
go back to reference Ferreira JP, Butler J, Rossignol P, Pitt B, Anker SD, Kosiborod M, Lund LH, Bakris GL, Weir MR, Zannad F (2020) Abnormalities of potassium in heart failure: JACC state-of-the-art review. J Am Coll Cardiol 75:2836–2850CrossRefPubMed Ferreira JP, Butler J, Rossignol P, Pitt B, Anker SD, Kosiborod M, Lund LH, Bakris GL, Weir MR, Zannad F (2020) Abnormalities of potassium in heart failure: JACC state-of-the-art review. J Am Coll Cardiol 75:2836–2850CrossRefPubMed
7.
go back to reference Tomasoni D, Adamo M, Lombardi CM, Metra M (2019) Highlights in heart failure. ESC Heart Fail 6:1105–1127CrossRefPubMed Tomasoni D, Adamo M, Lombardi CM, Metra M (2019) Highlights in heart failure. ESC Heart Fail 6:1105–1127CrossRefPubMed
8.
go back to reference Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR (2021) Clinical management of hyperkalemia. Mayo Clin Proc 96:744–762CrossRefPubMed Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR (2021) Clinical management of hyperkalemia. Mayo Clin Proc 96:744–762CrossRefPubMed
9.
go back to reference Formiga F, Chivite D, Corbella X, Conde-Martel A, Arévalo-Lorido JC, Trullàs JC, Silvestre JP, García SC, Manzano L, Montero-Pérez-Barquero M, RICA investigators group (2019) Influence of potassium levels on 1 year outcomes in elderly patients with acute heart failure. Eur J Intern Med 60:24–30CrossRefPubMed Formiga F, Chivite D, Corbella X, Conde-Martel A, Arévalo-Lorido JC, Trullàs JC, Silvestre JP, García SC, Manzano L, Montero-Pérez-Barquero M, RICA investigators group (2019) Influence of potassium levels on 1 year outcomes in elderly patients with acute heart failure. Eur J Intern Med 60:24–30CrossRefPubMed
10.
go back to reference Núñez J, Bayés-Genís A, Zannad F, Rossignol P, Núñez E, Bodí V, Miñana G, Santas E, Chorro FJ, Mollar A, Carratalá A, Navarro J, Górriz JL, Lupón J, Husser O, Metra M, Sanchis J (2018) Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation 137:1320–1330CrossRefPubMed Núñez J, Bayés-Genís A, Zannad F, Rossignol P, Núñez E, Bodí V, Miñana G, Santas E, Chorro FJ, Mollar A, Carratalá A, Navarro J, Górriz JL, Lupón J, Husser O, Metra M, Sanchis J (2018) Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation 137:1320–1330CrossRefPubMed
12.
go back to reference Kitamura M, Izawa KP, Taniue H, Mimura Y, Ikeda Y, Nagashima H, Brubaker PH (2018) Activities of daily living at different levels of renal function in elderly hospitalized heart failure patients. Aging Clin Exp Res 30:45–51CrossRefPubMed Kitamura M, Izawa KP, Taniue H, Mimura Y, Ikeda Y, Nagashima H, Brubaker PH (2018) Activities of daily living at different levels of renal function in elderly hospitalized heart failure patients. Aging Clin Exp Res 30:45–51CrossRefPubMed
13.
go back to reference Zhang Z, Cao L, Chen R, Zhao Y, Lv L, Xu Z, Xu P (2021) Electronic healthcare records and external outcome data for hospitalized patients with heart failure. Sci Data 8:46CrossRefPubMedPubMedCentral Zhang Z, Cao L, Chen R, Zhao Y, Lv L, Xu Z, Xu P (2021) Electronic healthcare records and external outcome data for hospitalized patients with heart failure. Sci Data 8:46CrossRefPubMedPubMedCentral
14.
go back to reference Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE (2000) Physio bank, physiotoolkit, and physionet: components of a new research resource for complex physiologic signals. Circulation 101:E215–E220CrossRefPubMed Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE (2000) Physio bank, physiotoolkit, and physionet: components of a new research resource for complex physiologic signals. Circulation 101:E215–E220CrossRefPubMed
15.
go back to reference Duflos C, Troude P, Strainchamps D, Ségouin C, Logeart D, Mercier G (2020) Hospitalization for acute heart failure: the in-hospital care pathway predicts 1 year readmission. Sci Rep 10:10644CrossRefPubMedPubMedCentral Duflos C, Troude P, Strainchamps D, Ségouin C, Logeart D, Mercier G (2020) Hospitalization for acute heart failure: the in-hospital care pathway predicts 1 year readmission. Sci Rep 10:10644CrossRefPubMedPubMedCentral
16.
go back to reference Toledo CC, Vellosa Schwartzmann P, Miguel Silva L, da Silva FG, Bianchini Cardoso F, Citelli Ribeiro V, Paim LR, Antunes-Correa LM, Carvalho Sposito A, Matos Souza JR, Modolo R, Nadruz W, de FernandesCarvalho LS, Coelho-Filho OR (2021) Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables. ESC Heart Fail 8:2133–2143CrossRefPubMedPubMedCentral Toledo CC, Vellosa Schwartzmann P, Miguel Silva L, da Silva FG, Bianchini Cardoso F, Citelli Ribeiro V, Paim LR, Antunes-Correa LM, Carvalho Sposito A, Matos Souza JR, Modolo R, Nadruz W, de FernandesCarvalho LS, Coelho-Filho OR (2021) Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables. ESC Heart Fail 8:2133–2143CrossRefPubMedPubMedCentral
17.
go back to reference Gao XP, Zheng CF, Liao MQ, He H, Liu YH, Jing CX, Zeng FF, Chen QS (2019) Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort study. BMC Nephrol 20:311CrossRefPubMedPubMedCentral Gao XP, Zheng CF, Liao MQ, He H, Liu YH, Jing CX, Zeng FF, Chen QS (2019) Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort study. BMC Nephrol 20:311CrossRefPubMedPubMedCentral
18.
go back to reference Pugliese NR, De Biase N, Gargani L, Mazzola M, Conte L, Fabiani I, Natali A, Dini FL, Frumento P, Rosada J, Taddei S, Borlaug BA, Masi S (2021) Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing. Eur J Prev Cardiol 28:1650–1661CrossRefPubMed Pugliese NR, De Biase N, Gargani L, Mazzola M, Conte L, Fabiani I, Natali A, Dini FL, Frumento P, Rosada J, Taddei S, Borlaug BA, Masi S (2021) Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing. Eur J Prev Cardiol 28:1650–1661CrossRefPubMed
19.
go back to reference Eriguchi M, Tsuruya K, Lopes M, Bieber B, McCullough K, Pecoits-Filho R, Robinson B, Pisoni R, Kanda E, Iseki K, Hirakata H (2022) Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients. ESC Heart Fail 9:1138–1151CrossRefPubMedPubMedCentral Eriguchi M, Tsuruya K, Lopes M, Bieber B, McCullough K, Pecoits-Filho R, Robinson B, Pisoni R, Kanda E, Iseki K, Hirakata H (2022) Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients. ESC Heart Fail 9:1138–1151CrossRefPubMedPubMedCentral
20.
go back to reference Vaduganathan M, Pareek M, Kristensen AMD, Biering-Sørensen T, Byrne C, Almarzooq Z, Olesen TB, Olsen MH, Bhatt DL (2021) Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy. Eur J Heart Fail 23:384–392CrossRefPubMed Vaduganathan M, Pareek M, Kristensen AMD, Biering-Sørensen T, Byrne C, Almarzooq Z, Olesen TB, Olsen MH, Bhatt DL (2021) Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy. Eur J Heart Fail 23:384–392CrossRefPubMed
21.
go back to reference Morales E, Cravedi P, Manrique J (2021) Management of chronic hyperkalemia in patients with chronic kidney disease: an old problem with news options. Front Med (Lausanne) 8:653634CrossRefPubMed Morales E, Cravedi P, Manrique J (2021) Management of chronic hyperkalemia in patients with chronic kidney disease: an old problem with news options. Front Med (Lausanne) 8:653634CrossRefPubMed
22.
go back to reference Villa-Zapata L, Carhart BS, Horn JR, Hansten PD, Subbian V, Gephart S, Tan M, Romero A, Malone DC (2021) Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: a systematic review and meta-analysis. Am J Health Syst Pharm 78:2245–2255CrossRefPubMed Villa-Zapata L, Carhart BS, Horn JR, Hansten PD, Subbian V, Gephart S, Tan M, Romero A, Malone DC (2021) Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: a systematic review and meta-analysis. Am J Health Syst Pharm 78:2245–2255CrossRefPubMed
24.
go back to reference Sfairopoulos D, Arseniou A, Korantzopoulos P (2021) Serum potassium and heart failure: association, causation, and clinical implications. Heart Fail Rev 26:479–486CrossRefPubMed Sfairopoulos D, Arseniou A, Korantzopoulos P (2021) Serum potassium and heart failure: association, causation, and clinical implications. Heart Fail Rev 26:479–486CrossRefPubMed
25.
go back to reference Liu S, Zhao D, Wang M, Qi Y, Sun J, Liu J, Li Y, Liu J (2021) Association of serum potassium levels with mortality and cardiovascular events: findings from the Chinese multi-provincial cohort study. J Gen Intern Med 37(10):2446–2453CrossRefPubMed Liu S, Zhao D, Wang M, Qi Y, Sun J, Liu J, Li Y, Liu J (2021) Association of serum potassium levels with mortality and cardiovascular events: findings from the Chinese multi-provincial cohort study. J Gen Intern Med 37(10):2446–2453CrossRefPubMed
26.
go back to reference Brunelli SM, Spiegel DM, Du Mond C, Oestreicher N, Winkelmayer WC, Kovesdy CP (2018) Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant 33(7):1207–1214CrossRefPubMed Brunelli SM, Spiegel DM, Du Mond C, Oestreicher N, Winkelmayer WC, Kovesdy CP (2018) Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant 33(7):1207–1214CrossRefPubMed
27.
go back to reference Hagengaard L, Søgaard P, Espersen M, Sessa M, Lund PE, Krogager ML, Torp-Pedersen C, Kragholm KH, Polcwiartek C (2020) Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs. Eur Heart J Cardiovasc Pharmacother 6:137–144CrossRefPubMed Hagengaard L, Søgaard P, Espersen M, Sessa M, Lund PE, Krogager ML, Torp-Pedersen C, Kragholm KH, Polcwiartek C (2020) Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs. Eur Heart J Cardiovasc Pharmacother 6:137–144CrossRefPubMed
28.
go back to reference Falk RS, Robsahm TE, Paulsen JE, Stocks T, Drake I, Heir T (2021) Fasting serum potassium and long-term mortality in healthy men. BMC Public Health 21:711CrossRefPubMedPubMedCentral Falk RS, Robsahm TE, Paulsen JE, Stocks T, Drake I, Heir T (2021) Fasting serum potassium and long-term mortality in healthy men. BMC Public Health 21:711CrossRefPubMedPubMedCentral
29.
go back to reference Li Z, Zhao H, Wang J (2021) Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities. Front Cardiovasc Med 8:650278CrossRefPubMedPubMedCentral Li Z, Zhao H, Wang J (2021) Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities. Front Cardiovasc Med 8:650278CrossRefPubMedPubMedCentral
30.
go back to reference Gargiulo P, Marsico F, Renga F, Dell’Aversana S, Esposito I, Marciano C, Dellegrottaglie S, Perrone-Filardi P, Paolillo S (2020) The metabolic syndrome in heart failure: insights to specific mechanisms. Heart Fail Rev 25:1–7CrossRefPubMed Gargiulo P, Marsico F, Renga F, Dell’Aversana S, Esposito I, Marciano C, Dellegrottaglie S, Perrone-Filardi P, Paolillo S (2020) The metabolic syndrome in heart failure: insights to specific mechanisms. Heart Fail Rev 25:1–7CrossRefPubMed
31.
go back to reference Neuen BL, Oshima M, Perkovic V, Agarwal R, Arnott C, Bakris G, Cannon CP, Charytan DM, Edwards R, Górriz JL, Jardine MJ, Levin A, Neal B, De Nicola L, Pollock C, Rosenthal N, Wheeler DC, Mahaffey KW, Heerspink HJL (2021) Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. Eur Heart J 42(48):4891–4901CrossRefPubMed Neuen BL, Oshima M, Perkovic V, Agarwal R, Arnott C, Bakris G, Cannon CP, Charytan DM, Edwards R, Górriz JL, Jardine MJ, Levin A, Neal B, De Nicola L, Pollock C, Rosenthal N, Wheeler DC, Mahaffey KW, Heerspink HJL (2021) Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. Eur Heart J 42(48):4891–4901CrossRefPubMed
Metadata
Title
Serum potassium in elderly heart failure patients as a predictor of readmission within 1 year
Authors
Gechu Shang
Yan Gao
Kewei Liu
Xiaoyong Wang
Publication date
01-11-2022
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 4/2023
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02192-y

Other articles of this Issue 4/2023

Heart and Vessels 4/2023 Go to the issue